Shentong Zhuyu Decoction Inhibits Inflammatory Response, Migration, and Invasion and Promotes Apoptosis of Rheumatoid Arthritis Fibroblast-like Synoviocytes via the MAPK p38/PPAR<i>γ</i>/CTGF Pathway

Han, Ying; Wang, Jing; Jin, Meng; Jia, Lin; Yan, Cuihuan; Wang, Yali

doi:https://doi.org/10.1155/2021/6187695

BioMed Research International

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2021 | Article ID 6187695 | https://doi.org/10.1155/2021/6187695

Shentong Zhuyu Decoction Inhibits Inflammatory Response, Migration, and Invasion and Promotes Apoptosis of Rheumatoid Arthritis Fibroblast-like Synoviocytes via the MAPK p38/PPARγ/CTGF Pathway

Ying Han,^1,2Jing Wang,³Meng Jin,²Lin Jia,⁴Cuihuan Yan,⁵and Yali Wang¹

Academic Editor: Marta Laranjo

Received17 Aug 2020

Revised23 Dec 2020

Accepted29 Dec 2020

Published16 Jan 2021

Abstract

Introduction. The current study is aimed at exploring the effect of Shentong Zhuyu Decoction on the proliferation, migration, invasion, and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) and its underlying molecular mechanism. Materials and Methods. The type II collagen-induced arthritis (CIA) model was established. Subsequently, the RA-FLS were isolated from the CIA rat model and identified by immunohistochemistry. The viability, apoptosis, cell cycle, migration, and invasion of RA-FLS were detected by the cell counting kit 8 (CCK-8) assay, flow cytometry, wound-healing assay, and transwell invasion assay, respectively. The levels of MAPK p38, PPARγ, CTGF, Bcl-2, Bax, caspase-3, IL-1β, MMP-3, CDK4, and cyclin D1 were determined by qRT-PCR and western blotting, respectively. Results. After treatment with Shentong Zhuyu Decoction medicated serum, the OD₅₇₀ value, migrative and invasive abilities, and the secretion of IL-1β, MMP-3 were remarkably decreased in RA-FLS, while the apoptosis rate was increased. Further, results showed that Shentong Zhuyu Decoction inhibited the transition from the G1 phase to S phase. Additionally, Shentong Zhuyu Decoction significantly inhibited the expression of Bcl-2, CDK4, cyclin D1, MAPK p-p38, and CTGF, whereas elevated the levels of Bax, caspase-3, and PPARγ. Importantly, the effects of Shentong Zhuyu Decoction were consistent with the trends of MAPK P38 inhibitor (SB203580) and PPARγ agonist (GW1929). Conclusions. Shentong Zhuyu Decoction inhibited viability, inflammatory response, migration, invasion, and transition from the G1 phase to S phase and promoted apoptosis of RA-FLS via the MAPK p38/PPARγ/CTGF pathway.

1. Introduction

Rheumatoid arthritis (RA) is a chronic autoimmune disease with high prevalence and disability, which involves in multiple joints throughout the body [1, 2]. Currently, the treatment of RA is mainly based on drugs and surgeries [3]. However, high costs seriously trouble the patients, and treatments are far from meeting the needs of RA patients. Furthermore, the pathology of RA is still unclear [4]. As we known, fibroblast-like synoviocytes (FLS) show tumor-like characteristics, which are considered to be the “leader cells” in terms of promoting the persistence and destructiveness in disease. Moreover, FLS play a major role on recurrence, long-term cure, and poor prognosis of RA [5, 6]. Previous research has found that targeted treatment for FLS improves the condition of RA and indicated that direct regulation of FLS may become the next target for RA treatment [7]. Therefore, exploring the underlying mechanism and seeking for new therapy are urgent for public health.

Previous study has indicated that the mitogen-activated protein kinase (MAPK) family members play vital roles on progression of RA including MAPK p38, extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK). In particular, MAPK p38 is involved in the upregulation of proinflammatory cytokines [8]. Moreover, the MAPK p38 pathway has been proved to participate in the activation of RA-FLS [9, 10]. Peroxisome proliferator-activated receptors (PPARs) are known as ligand-activated transcription factors. In terms of RA, a previous study has demonstrated that activation of PPARγ can effectively suppress the inflammatory response [11]. In addition, connective tissue growth factor (CTGF) is a downstream molecule of PPARγ [12] and plays a critical role on RA progression, which is verified, respectively [13]. Furthermore, a previous study has indicated that activation of MAPK p38 negatively regulates PPARγ [14]. Therefore, we hypothesized that the MAPK p38/PPARγ/CTGF pathway may involve in RA progression.

More and more evidence have demonstrated that traditional Chinese herbs including liquiritin, berberine, salicin, imperatorin, and paeonol play vital roles on the proliferation, inflammation, and angiogenesis in the RA [15–19]. Furthermore, Duan et al. [20] have indicated the synergistic mechanism of four effective components of compound Fengshiding capsule against RA by network pharmacology, which may provide basis for the further study on compound preparation of traditional Chinese medicine. Shentong Zhuyu Decoction consists of about 12 kinds of traditional Chinese medicine, which plays roles on promoting blood circulation and removing blood stasis [21]. Moreover, previous studies have demonstrated that Shentong Zhuyu Decoction inhibits the inflammatory response and alleviates the pain behaviors [22, 23]. However, whether Shentong Zhuyu Decoction regulates the molecular mechanism of RA-FLS via the MAPK p38/PPARγ/CTGF pathway has not reported yet.

The current study is aimed at exploring the effect of Shentong Zhuyu Decoction on the proliferation, migration, invasion, and apoptosis of RA-FLS and its underlying molecular mechanism via the MAPK p38/PPARγ/CTGF pathway. Our findings may provide the novel therapy for treated with RA.

2. Materials and Methods

2.1. Animal Model

Sprague-Dawley (SD) rats were purchased from Liaoning Changsheng Biotechnology Co., Ltd. (Shenyang, China). The collagen-induced arthritis (CIA) rat model was established as previously described [24]. Briefly, type II collagen (CII, 10 mg) was dissolved in acetic acid (0.1 mol/L) and then mixed with an equal amount of complete Freund’s adjuvant (CFA). Subsequently, rats were injected with CII emulsion (100 μL) in the root of the tail, respectively. After 7 days, the immunization was repeated again with the same dosage in the same site. The rats were injected with normal saline of equal volume, which is deemed as control. On the 14^th days of modeling, a marked swelling of the toe and ankle joint was observed.

The arthritis scores of CIA rats were evaluated by the scoring criteria [25]. In brief, 0 point indicated no erythema and swelling, 1 point indicated mild erythema and swelling of the mid-foot or ankle joint, 2 points indicated mild erythema and swelling extending from the ankle to mid-foot, 3 points indicated moderate swelling extending from the ankle to the metatarsal joints, and 4 points indicated that severe swelling encompass the ankle, foot, and digits. The maximum arthritic score per rats was 16. In general, are deemed as an indicator for successful modeling [26]. The paw swelling of CIA rats was assessed by measuring the circumference of the paw, as previously described [27]. Oedema was expressed in percentage compared with the initial control values.

The parameters of the CIA model in the current study indicated that the levels of and rheumatoid factor (RF) and C-reactive protein (CRP) were () IU/mL and () mg/L, paw swelling was (%), and arthritis score was . So, the rats with abovementioned parameters were regarded as the successful CIA rat model and then were used for subsequent experiments.

2.2. Prepare the Shentong Zhuyu Decoction

The Shentong Zhuyu Decoction consisted of Gentiana macrophylla (3 g), Ligusticum wallichii (6 g), Peach Kernel (9 g), Safflower (9 g), Licorice (6 g), Notopterygium (3 g), Myrrh (6 g), Angelica (9 g), Trogopterus dung (6 g), Rhizoma Cyperi (3 g), Achyranthes (9 g), Earthworm (6 g), Cortex phellodendri (6 g), and Rhizoma Atractylodis (6 g). Abovementioned herbs were Chinese medicine dispensing granules, which were purchased from Shenwei Pharmaceutical Group Co., Ltd. (Beijing, China). 1 dose of Chinese medicine dispensing granules was equivalent to 87 g of crude drug, which added boiling water (55.55 mL) to make the drug concentration of 1.566 g/mL.

2.3. Medicated Serum Preparation

The dosage of Shentong Zhuyu Decoction was converted by the human and animal body surface area, determining by the common clinical dosage, which was about 15.66 g/kg/d. The normal rats were gavaged by Shentong Zhuyu Decoction (2 mL) and distilled water (2 mL) for 7 days, respectively. Two hours after the last administration, the rats were anesthetized, and 5 mL of blood was drawn from the abdominal aorta. The blood was centrifuged at 1000 × g for 10 min after stood for 30 min at room temperature. Following, the drug-containing serum and control serum were collected and stored at -80°C. Finally, the drug-containing serum was added into culture medium to detect the effect on RA-FLS, with volume fractions of 5% (low-dose group), 10% (medium-dose group), and 20% (high-dose group), respectively. The appropriate concentration of drug-containing serum was screened using the MTT assay.

2.4. Cell Isolation and Identification

The synovial tissues were taken from normal and CIA rats and cut and digested with DNase (0.15 mg/mL), hyaluronidase (0.15 mg/mL), and collagenase (1 mg/mL). The normal FLS (normal FLS) and RA-FLS were obtained and resuspended with DMEM medium (Gibco, Gaithersburg, MD, USA) containing 10% fetal bovine serum (FBS, Tianhang Biotechnology Co., Ltd, Hangzhou, China), 30 mg/mL glutamine (Solarbio, Shanghai, China), 2.5 μg/mL amphotericin B (Sigma-Aldrich, St. Louis, Mo, USA), and 10 μg/mL gentamicin (Gibco). After the overnight culture, the nonadherent cells were removed, and adherent cells were routinely cultured.

The RA-FLS were identified by immunohistochemistry. In brief, the cells ( cells/mL) were cultured in 12-well plate for 48 h. Subsequently, cells were fixed with 4% paraformaldehyde and incubated with 0.1% TritonX-100 and 3% hydrogen peroxide. After washed, anti-Vimentin (1: 200, Wanleibio, Shenyang, China) and anti-CD68 (1: 200, Affinity Biosciences, OH, USA) were added and incubated overnight at 4°C. Following, horseradish peroxidase- (HRP-) labeled goat anti-rabbit IgG was added and incubated overnight at 37°C for 60 min. Finally, the cells were stained with diaminobenzidine (DAB) and hematoxylin. The images were captured by inverted microscope (BX53, Olympus, Tokyo, Japan).

2.5. Cell Treatment and Grouping

The cells in the logarithmic phase of growth were collected and cultured in 96-well plates ( cells/mL). After the cells were adhered, different drugs were intervened for 48 h. The experiment was divided into 5 groups. Among them, normal FLS were cultured in DMEM medium plus 20% control serum (normal group). RA-FLS were cultured in DMEM medium plus 20% control serum, P38 mitogen-activated protein kinase inhibitor (MAPK P38 inhibitor, SB203580, 20 μmol/L), peroxisome proliferator-activated receptor gamma agonist (PPARγ agonist, GW1929, 30 μmol/L), and 20% drug-containing serum, which were named as the blank group, P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group, respectively.

2.6. Cell Viability Assay

Cell viability was detected by the cell counting kit 8 (CCK-8) assay. Cells ( cells/mL) were seeded in 96-well plates and then intervened with drug for 48 h. CCK-8 solution was added into per well and incubated for 2 h. The OD₅₇₀ values were measured by microplate reader (ELX-800, Biotek, Winooski, VT, USA).

2.7. Cell Apoptosis Assay

After 48 h treatment, FLS were collected, washed with cool phosphate buffer saline (PBS) and resuspended. The cell apoptosis was conducted by flow cytometry (NovoCyte, ACEA Bioscience, San Diego, California, USA) using Annexin V-FITC apoptosis detection kit (Wanleibio).

2.8. Cell Cycle Assay

After 48 h treatment, FLS were collected, fixed with 75% ethanol, and washed with cool PBS. Subsequently, RNA enzyme-containing propidium iodide (PI) solution was added for incubation. Finally, the cell cycle was detected by instrument (NovoCyte, ACEA Bioscience).

2.9. Wound-Healing Assay

After treatment, FLS were cultured in 6-well plates ( cells/mL) overnight. The wound was obtained by using a 200 μL pipette tip on the center of the cell monolayer. Images were captured at 0 h and 48 h, and the migrative distance was assessed by Image pro plus software.

2.10. Transwell Invasion Assay

The cells ( cells/mL) were grown in the top chamber with Matrigel (BD Bioscience, Franklin Lakes, NJ, USA), and DMEM medium was added in the lower chamber. After 48 h, the invasive cells were fixed with 4% paraformaldehyde and the stained with 0.4% crystal violet (Amresco, Cleveland, OH, USA). Finally, the amount of cells was calculated via microscope (IX53, Olympus).

2.11. Quantitative Real-Time RT-PCR

Total RNA was extracted from cells using TRIpure isolation reagent (BioTeke, Beijing, China). qRT-PCR analysis was performed as previously described [28]. Briefly, first-strand cDNA was synthesized from total RNA using cDNA synthesis kit (BioTeke). Then, real-time PCR was performed using the SYBR Green kit (Solarbio) and detected by Exicycler TM 96 (Bioneer, Daejeon, Korea). GAPDH was acted as internal control. The primer sequences were synthesized by GenScript Biotechnology (Nanjing, China) and listed as the following: MAPK p38 forward, TAAAGCCCAGCAACCTCG, reverse, CAGCCCACGGACCAAATA; PPARγ forward, TACCACGGTTGATTTCTC, reverse, AATAATAAGGCGGGGACG; CTGF forward, GTCTTCGGTGGGTCCGTGTA, reverse, GCGGTCCTTGGGCTCATCAC; CyclinD1 forward, GAGGAGCAGAAGTGCGAAGA, reverse, GGCGGATAGAGTTGTCAGTGTAG; caspase-3 forward, GACGACAGGGTGCTACGAT, reverse, TTTCCTTACGCTCTGACTGA; β-actin forward, GGAGATTACTGCCCTGGCTCCTAGC, reverse, GGCGGACTCATCGTACTCCTGCTT. The reaction was conducted with an initial denaturing step at 94°C for 5 min, followed by 40 cycles of 94°C for 10 s, 60°C for 20 s, and 72°C for 30 s. The relative expression was analyzed by the 2^-ΔΔCt method.

2.12. Western Blotting

Protein samples were extracted by RIPA buffer, and the concentration was measured by the BCA kit. Protein was separated by SDS-PAGE and then was transferred into polyvinylidene difluoride (PVDF) membrane. After that, membranes were blocked with 5% skim milk, incubated overnight at 4°C with monoclonal anti-β-actin antibody, anti-p38 antibody, anti-p-p38 antibody, anti-CTGF antibody, anti-MMP-3 antibody, and anti-IL-1βantibody (1: 1000, Wanleibio), and then incubated with the horseradish peroxidase- (HRP-) conjugated secondary antibody (1: 10000, Wanleibio) for 50 min. Immunodetection was performed using enhanced chemiluminescence reagent (Wanleibio), and then the protein band was detected using Gel-Pro-Analyzer program (Media Cybernetics, Rockville, MD, USA). β-actin was used as internal control.

2.13. Statistical Analysis

All data were statistically analyzed with SAS 9.1 software. The measurement data were expressed as (SD). The differences between two groups were analyzed by the -test. The comparison of multiple groups was calculated with one-way analysis of variance (ANOVA) and followed by the LSD -test. was considered as statistically significant.

3. Results

3.1. RA-FLS Identification

After cultured 3 generations, RA-FLS presented typically fibroblast-like morphology, which was characterized by elongated spindle-shaped, elongated protrusions, nucleus-centered, round, or oval shape and arrangement of polarity. The results of immunohistochemistry showed that anti-Vimentin antibody was positive, and anti-CD68 antibody was negative (Figures 1(a) and 1(b)). Abovementioned results were in accordance with the characteristics of RA-FLS.

(a)

(b)

3.2. Screening of Concentration of Shentong Zhuyu Decoction Medicated Serum

MTT results showed that the OD₅₇₀ value was significantly decreased in the high-dose group compared with the NC group (), indicating that intervention with 20% drug-containing serum for 24 h can be effectively suppressed the proliferation of RA-FLS (Figure 2(a)). Subsequently, the intervention time among different groups indicated that the OD₅₇₀ value in the high-dose group at 24 h was slightly decreased, while not obviously different compared with the NC group. However, the OD₅₇₀ value of the high-dose group at 48 h and 72 h was significantly lower than those of the NC group and control serum group () (Figure 2(b)). Those findings suggested that 20% drug-containing serum treated for 48 h was selected as the intervention conditions for the subsequent study.

(a)

(b)

3.3. Shentong Zhuyu Decoction Inhibited Viability and Promoted Apoptosis of RA-FLS

The results of flow cytometry showed that the apoptosis rate in the blank group was lower than that in the normal group (). In addition, the apoptosis rates in the P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group were remarkably increased compared with the blank group () (Figures 3(a) and 3(b)). Moreover, CCK-8 assay results indicated that the trend of the OD₅₇₀ value was contrary to that of the apoptosis rate (Figure 3(c)). All data of qRT-PCR and western blotting demonstrated that the levels of Bax and caspase-3 in the blank group were lower than those in the normal group () and higher than in the P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group (). Meanwhile, the expression of Bcl-2 was opposite to that of Bax and caspase-3 (Figures 3(d)–3(f)). However, the OD₅₇₀ value and apoptosis rate were not significant difference among the P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group ().

(a)

(b)

(c)

(d)

(e)

(f)

Figure 3

The effects of Shentong Zhuyu Decoction on RA-FLS. (a, b) The apoptosis rate of RA-FLS was detected by flow cytometry. (c) The OD₅₇₀ value of RA-FLS was detected by the CCK-8 assay. (d) The mRNA levels of Bax, Bcl-2, and caspase-3 in RA-FLS were tested by qRT-PCR. (e, f) The protein levels of Bax, Bcl-2, and caspase-3 in RA-FLS were tested by western blotting. compared with the normal group, ^# compared with the blank group, ^& compared with the P38 inhibitor group, and ^@ compared with the PPARγ agonist group.

3.4. Shentong Zhuyu Decoction Influenced the Cell Cycle of RA-FLS

As shown in Figures 4(a) and 4(b), the cell proportion in the S phase was notably increased while the G1 phase was notably decreased in the blank group contrasted with the normal group (all ). In addition, the RA-FLS proportion in the S phase was remarkably reduced, whereas significantly elevated in the G1 phase in the P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group contrasted with the blank group (). However, cell proportion in the G2 phase was not obvious changes among different groups (). Furthermore, the results of qRT-PCR and western blotting indicated that the levels of cyclin D1 and CDK 4 in the blank group were higher than those in the normal group (), whereas P38 inhibitor, PPARγ agonist, and Shentong Zhuyu Decoction suppressed the expressions of cyclin D1 and CDK4 (). Among the treatment groups in RA-FLS, the effects of P38 inhibitor on the expression of cyclin D1 and CDK4 were equivalent to the PPARγ agonist (), while prior to the Shentong Zhuyu Decoction () (Figures 4(c)–4(e)). All results suggested that Shentong Zhuyu Decoction inhibited the transition from the G1 phase to S phase of RA-FLS.

(a)

(b)

(c)

(d)

(e)

3.5. Shentong Zhuyu Decoction Inhibited Migration and Invasion of RA-FLS

As shown in Figures 5(a) and 5(b), the wound-healing rate in the blank group was faster than that in the normal group () and slower than that in the P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group (). Beyond that, the results of the transwell assay revealed that the numbers of invasive cells in the blank group were dramatically increased compared with the normal group, while were significantly decreased after intervened with P38 inhibitor, PPARγ agonist, and Shentong Zhuyu Decoction () (Figures 5(c) and 5(d)). Of these, the impact of P38 inhibitor and PPARγ agonist on migration and invasion was stronger than Shentong Zhuyu Decoction (). Those findings suggested that Shentong Zhuyu Decoction inhibited the migration and invasion of RA-FLS.

(a)

(b)

(c)

(d)

3.6. Shentong Zhuyu Decoction Inhibited the Inflammatory Response of RA-FLS

The results showed that the levels of IL-1β and MMP-3 in the blank group were obviously increased compared with the normal group (). When intervened with P38 inhibitor, PPARγ agonist, and Shentong Zhuyu Decoction, the levels of IL-1β and MMP-3 were markedly reduced (). In addition, the effect of PPARγ agonist on the IL-1β expression was stronger than P38 inhibitor and Shentong Zhuyu Decoction (). However, the MMP-3 expression in the Shentong Zhuyu Decoction group was higher than that in the P38 inhibitor group and PPARγ agonist group () (Figures 6(a)–6(c)).

(a)

(b)

(c)

3.7. Shentong Zhuyu Decoction Influenced the MAPK p38/PPARγ/CTGF Pathway

In order to explain the different effects of P38 inhibitor, PPARγ agonist, and Shentong Zhuyu Decoction on the RA-FLS, we investigated the expression of the MAPK p38/PPARγ/CTGF pathway. As shown in Figures 7(a)–7(c), the mRNA and total protein levels of MAPK p38 were not obviously changes among the different groups (). Additionally, compared with the normal group, the levels of MAPK p-p38 and CTGF were markedly elevated, while the PPARγ level was markedly reduced in the blank group (). Furthermore, P38 inhibitor, PPARγ agonist, and Shentong Zhuyu Decoction all can reverse the expression of MAPK p-p38, PPARγ, and CTGF in the RA-FLS ().

(a)

(b)

(c)

We also found that the MAPK p-p38 expression in the P38 inhibitor group was lower than that in the PPARγ agonist group. In terms of the PPARγ expression, the effect of PPARγ agonist was higher than P38 inhibitor, whereas the level of CTGF was not obviously different in the two groups. So, we speculated that MAPK p-p38 may be upstream of PPARγ, and CTGF may be jointly regulated by MAPK p-p38 and PPARγ. In addition, the levels of MAPK p-p38 and CTGF were significantly decreased, and the PPARγ level was notably elevated after intervention with Shentong Zhuyu Decoction in the RA-FLS (Figures 7(a)–7(c)). Abovementioned results indicated that Shentong Zhuyu Decoction may inhibit proliferation, migration, and invasion and promote apoptosis in the RA-FLS via regulating the MAPK p38/PPARγ/CTGF pathway.

4. Discussion

RA pathogenesis is a systemic chronic inflammatory disease that is characterized as synovial cell proliferation with inflammatory infiltration, leading to joint damage [4]. RA-FLS not only play the role in the inflammatory secretion but also manifest tumor-like phenotype with high proliferation, migration, and invasion [29]. So, targeting RA-FLS is important for treatment for RA. Currently, the drugs are available including methotrexate, glucocorticoids, and ibuprofen, which may cause some side effects. Beyond that, some biological drugs including tocilizumab and tofacitinib are expensive for clinical treatment [30]. In past decades, traditional Chinese medicine explains the pathogenesis of RA and holds the treatment on the basis of symptoms and signs [20, 31]. Shentong Zhuyu Decoction is a classic representative formula for promoting blood circulation proposed by Qingren wang, which consists of 12 kinds of tradition Chinese herbs, including Gentiana macrophylla, Ligusticum wallichii, Peach Kernel, Safflower, Licorice, Notopterygium, Myrrh, Angelica, Trogopterus dung, Rhizoma Cyperi, Achyranthes, and Earthworm [21]. In the current study, the compound decoction added more 2 kinds of Chinese herbs on the basis of the above formula including Cortex phellodendri and Rhizoma Atractylodis to strengthen its power of dispelling wind, removing dampness, and clearing heat. Previous studies have proved that the combination of Cortex phellodendri and Rhizoma Atractylodis (Er-Miao-San) exhibits antiarthritic activity via regulating the balance of cytokines [32, 33]. The major finding of our study was that Shentong Zhuyu Decoction can inhibit the inflammatory response, migration, and invasion and promote apoptosis of rheumatoid arthritis fibroblast-like synoviocytes via the MAPK p38/PPARγ/CTGF pathway.

Currently, induced by exogenous TNF-α and isolated from the synovial tissue are widely used for the RA model in vitro [34, 35]. In our study, the CIA rat model was established, and then RA-FLS were isolated and identified, as described previously [36]. The current study showed that the cells cultured for 3 generations were in accordance with the characteristics of RA-FLS. Additionally, we also found that the abilities of proliferation, migration, and invasion in the RA-FLS were elevated, while the apoptosis rate was reduced compared with normal FLS. Furthermore, a previous study has indicated that inducing apoptosis is deemed as the ideal therapy for RA patients [37]. As we all known, cell cycle consists of G1, G2, and S phase (interphase), and M phase (mitosis), which closely related to the cell proliferation and apoptosis. Moreover, cyclin D1 and CDK4 form a protein kinase complex, which participates in the regulation of restriction points in the G1 phase and then promotes cells transited to the S phase [38]. In terms of transition of the cell cycle in RA-FLS, Zhang et al. [39] have demonstrated that aspirin inhibits transition from the G1 phase to S phase and then promotes apoptosis and inhibits proliferation. Surprisingly, our study demonstrated that Shentong Zhuyu Decoction can suppress the transition from the G1 phase to S phase via inhibiting expressions of cyclin D1 and CDK4 in RA-FLS. Beyond that, we found that Shentong Zhuyu Decoction promoted the apoptosis rate of RA-FLS. In addition, the levels of Bax, Bcl-2, and caspase-3 confirmed the results of the apoptosis. The proteins (Bax, Bcl-2, and caspase-3) play crucial parts in apoptosis [31]. Abovementioned findings suggested that Shentong Zhuyu Decoction may become the targeting therapy for RA via regulating the cell biological behavior.

Inflammatory responses are the general event in RA patients, so antiinflammation therapy may be an effective treatment for relieving the symptoms [4]. It is well known that proinflammatory cytokines stimulate inflammatory responses and are considered as the key regulator in the progress of RA such as IL-1β, TNF-α, IL-6, and IL-17A [40]. In addition, these proinflammatory cytokines can promote the secretion of MMPs, which have been reported [41, 42]. Furthermore, Liu et al. [43] have indicated that Shentong Zhuyu Decoction can inhibit the secretion of inflammatory cytokines, attenuate cell infiltration, and improve state of joint. Surprisingly, the results of current study showed that the levels of IL-1β and MMP-3 were notably decreased after consumption of Shentong Zhuyu Decoction, which were consistent with previous report. Therefore, our study indicated that Shentong Zhuyu Decoction can effectively suppress the inflammatory response.

Until now, more evidences have verified that the MAPK signaling pathway involves in the regulation of inflammation and angiogenesis of RA [44–46] . Generally, MAPK p38 plays an important role on the secretion of proinflammatory cytokines [8]. A previous study has reported that MAPK p38 is upregulated and activated in RA-FLS [47]. Furthermore, Zou et al. have proved that SB203580 (p38 inhibitor) reverses the behaviors of activated RA-FLS [48]. Additionally, Ji et al. [49] have reported that pioglitazone (PPARγ agonist) suppresses inflammation via blocking the MAPK p38 pathway. Subsequently, a similar study has indicated that pioglitazone can effectively reduce the expression of MAPK p38 [50]. Our study showed that the MAPK p-p38 expression in the P38 inhibitor group was lower than that in the PPARγ agonist group, and the PPARγ expression of the PPARγ agonist group was higher than that of the P38 inhibitor group. So, we speculated that MAPK p38 may be upstream of PPARγ, and there is a negative regulation relationship. CTGF is regarded as a novel mediator for cell growth, which was secreted by fibroblasts [51]. Apart from silencing of MAPK p38, it significantly decreases the CTGF expression, while PPARγ agonist reduced the CTGF level [52, 53]. In our study, the CTGF level was not obviously different between the P38 inhibitor group and PPARγ agonist group. Those findings indicated that CTGF may be jointly regulated by MAPK p-p38 and PPARγ. Furthermore, we also found that Shentong Zhuyu Decoction inhibited the levels of MAPK p-p38 and CTGF and promoted the PPARγ level. The results of Shentong Zhuyu Decoction were consistent with the trends of SB203580 and GW1929. Therefore, abovementioned results suggested that Shentong Zhuyu Decoction regulated the behaviors of RA-FLS via the MAPK p38/PPARγ/CTGF pathway.

The lack of research on Shentong Zhuyu Decoction in vitro is a limitation of this study. So, we will explore the effect of Shentong Zhuyu Decoction on the CIA model and verify the effect of drug-containing serum via administration of Shentong Zhuyu Decoction in vivo in the further.

5. Conclusions

The current study demonstrated that Shentong Zhuyu Decoction inhibited inflammatory response, transition from G1 phase to S phase, migration, and invasion and promoted apoptosis of RA-FLS via regulating the MAPK p38/PPARγ/CTGF pathway.

Data Availability

All data generated or analyzed in this study are included in this published article.

Conflicts of Interest

All authors have no potential conflicts of interest.

Acknowledgments

The study was funded by the Research on Weiqi Rhythm and Prescription Intervention Based on Metabonomics (GZR 81273609).

References

A. I. Catrina, C. I. Svensson, V. Malmstrom, G. Schett, and L. Klareskog, “Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis,” Nature Reviews Rheumatology, vol. 13, no. 2, pp. 79–86, 2017.
View at: Publisher Site | Google Scholar
G. S. Firestein and I. B. McInnes, “Immunopathogenesis of rheumatoid arthritis,” Immunity, vol. 46, no. 2, pp. 183–196, 2017.
View at: Publisher Site | Google Scholar
P. P. Tak and J. R. Kalden, “Advances in rheumatology: new targeted therapeutics,” Arthritis Research & Therapy, vol. 13, Supplement 1, p. S5, 2011.
View at: Publisher Site | Google Scholar
J. S. Smolen, D. Aletaha, and I. B. McInnes, “Rheumatoid arthritis,” The Lancet, vol. 388, no. 10055, pp. 2023–2038, 2016.
View at: Publisher Site | Google Scholar
M. C. Lebre, P. L. Vieira, M. W. Tang et al., “Synovial IL-21/TNF-producing CD4⁺ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes,” Journal of Leukocyte Biology, vol. 101, no. 3, pp. 775–783, 2017.
View at: Publisher Site | Google Scholar
A. Korb-Pap, J. Bertrand, J. Sherwood, and T. Pap, “Stable activation of fibroblasts in rheumatic arthritis-causes and consequences,” Rheumatology, vol. 55, Supplement 2, pp. ii64–ii67, 2016.
View at: Publisher Site | Google Scholar
A. Filer, “The fibroblast as a therapeutic target in rheumatoid arthritis,” Current Opinion in Pharmacology, vol. 13, no. 3, pp. 413–419, 2013.
View at: Publisher Site | Google Scholar
G. L. Johnson and R. Lapadat, “Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases,” Science, vol. 298, no. 5600, pp. 1911-1912, 2002.
View at: Publisher Site | Google Scholar
M. H. Tsai, M. C. Chi, and J. F. Hsu, “Urban particulate matter enhances ROS/IL-6/COX-II production by inhibiting microRNA-137 in synovial fibroblast of rheumatoid arthritis,” Cell, vol. 9, no. 6, p. 1378, 2020.
View at: Publisher Site | Google Scholar
H. du, X. Zhang, Y. Zeng et al., “A novel phytochemical, DIM, inhibits proliferation, migration, invasion and TNF-α induced inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients by targeting MAPK and AKT/mTOR signal pathway,” Frontiers in Immunology, vol. 10, p. 1620, 2019.
View at: Publisher Site | Google Scholar
T. H. Lin, C. H. Tang, K. Wu, Y. C. Fong, R. S. Yang, and W. M. Fu, “15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts,” Journal of Cellular Physiology, vol. 226, pp. 3242–3250, 2011.
View at: Google Scholar
S. W. Lee, J. Y. Won, W. J. Kim et al., “Snail as a potential target molecule in cardiac fibrosis: paracrine action of endothelial cells on fibroblasts through snail and CTGF axis,” Molecular Therapy, vol. 21, no. 9, pp. 1767–1777, 2013.
View at: Publisher Site | Google Scholar
W. Sun, J. Ma, H. Zhao et al., “Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis,” Arthritis Research & Therapy, vol. 22, no. 1, p. 61, 2020.
View at: Publisher Site | Google Scholar
C. Tian, X. Jin, X. Ye et al., “Long term intake of 0.1% ethanol decreases serum adiponectin by suppressing PPARγ expression via p38 MAPK pathway,” Food and Chemical Toxicology, vol. 65, pp. 329–334, 2014.
View at: Publisher Site | Google Scholar
K. F. Zhai, H. Duan, C. Y. Cui et al., “Liquiritin from glycyrrhiza uralensis attenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 67, no. 10, pp. 2856–2864, 2019.
View at: Publisher Site | Google Scholar
H. Wang, S. Tu, S. Yang et al., “Berberine modulates LPA function to inhibit the proliferation and inflammation of FLS-RA via p38/ERK MAPK pathway mediated by LPA1,” Evidence-based Complementary and Alternative Medicine, vol. 2019, Article ID 2580207, 12 pages, 2019.
View at: Publisher Site | Google Scholar
K. F. Zhai, H. Duan, G. J. Khan et al., “Salicin from Alangium chinense ameliorates rheumatoid arthritis by modulating the Nrf2-HO-1-ROS pathways,” Journal of Agricultural and Food Chemistry, vol. 66, no. 24, pp. 6073–6082, 2018.
View at: Publisher Site | Google Scholar
K. F. Zhai, H. Duan, Y. Chen et al., “Apoptosis effects of imperatorin on synoviocytes in rheumatoid arthritis through mitochondrial/caspase-mediated pathways,” Food & Function, vol. 9, no. 4, pp. 2070–2079, 2018.
View at: Publisher Site | Google Scholar
K. F. Zhai, H. Duan, L. Luo et al., “Protective effects of paeonol on inflammatory response in IL-1β-induced human fibroblast-like synoviocytes and rheumatoid arthritis progression via modulating NF-κB pathway,” Inflammopharmacology, vol. 25, no. 5, pp. 523–532, 2017.
View at: Publisher Site | Google Scholar
H. Duan, K. F. Zhai, G. J. Khan et al., “Revealing the synergistic mechanism of multiple components in compound Fengshiding capsule for rheumatoid arthritis therapeutics by network pharmacology,” Current Molecular Medicine, vol. 19, no. 4, pp. 303–314, 2019.
View at: Publisher Site | Google Scholar
X. J. Lin and C. Y. Chen, “Advances on study of treatment of lumbar disk herniation by Chinese medicinal herbs,” Zhongguo Zhong Yao Za Zhi, vol. 32, no. 3, pp. 186–191, 2007.
View at: Google Scholar
B. X. Ren, Z. L. Ma, and Y. Q. Jin, “Effect of shentong zhuyu decoction on pain behavior and spinal cord astrocytes model of osteocarcinoma pain,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 31, no. 3, pp. 381–385, 2011.
View at: Google Scholar
K. Sun, L.-G. Zhu, X. Wei et al., “Efficacy and safety of Shentong Zhuyu Decoction for lumbar disc herniation: systematic review and meta-analysis,” Zhongguo Zhong Yao Za Zhi, vol. 45, pp. 1159–1166, 2020.
View at: Google Scholar
J. Pu, F. F. Fang, X. Q. Li et al., “Matrine exerts a strong anti-arthritic effect on type II collagen-induced arthritis in rats by inhibiting inflammatory responses,” International Journal of Molecular Sciences, vol. 17, no. 9, p. 1410, 2016.
View at: Publisher Site | Google Scholar
E. F. Rosloniec, M. Cremer, A. H. Kang, L. K. Myers, and D. D. Brand, “Collagen-induced arthritis,” Current Protocols in Immunology, vol. 89, no. 1, 2010.
View at: Publisher Site | Google Scholar
M. A. Lim, B. Louie, D. Ford et al., “Development of the digital arthritis index, a novel metric to measure disease parameters in a rat model of rheumatoid arthritis,” Frontiers in Pharmacology, vol. 8, p. 818, 2017.
View at: Publisher Site | Google Scholar
L. W. Chou, J. Wang, P. L. Chang, and Y. L. Hsieh, “Hyaluronan modulates accumulation of hypoxia-inducible factor-1 alpha, inducible nitric oxide synthase, and matrix metalloproteinase-3 in the synovium of rat adjuvant-induced arthritis model,” Arthritis Research & Therapy, vol. 13, no. 3, p. R90, 2011.
View at: Publisher Site | Google Scholar
K. F. Zhai, J. R. Zheng, Y. M. Tang et al., “The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis,” British Journal of Pharmacology, vol. 174, no. 17, pp. 2818–2831, 2017.
View at: Publisher Site | Google Scholar
L. C. Huber, O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap, “Synovial fibroblasts: key players in rheumatoid arthritis,” Rheumatology, vol. 45, no. 6, pp. 669–675, 2006.
View at: Publisher Site | Google Scholar
D. Aletaha and J. S. Smolen, “Diagnosis and management of rheumatoid arthritis,” JAMA, vol. 320, no. 13, pp. 1360–1372, 2018.
View at: Publisher Site | Google Scholar
A. Zhang, Y. Wu, H. W. Lai, and D. T. Yew, “Apoptosis–a brief review,” Neuroembryology and Aging, vol. 3, pp. 47–59, 2005.
View at: Google Scholar
G. Chen, K. K. Li, C. H. Fung et al., “Er-Miao-San, a traditional herbal formula containing Rhizoma Atractylodis and Cortex Phellodendri inhibits inflammatory mediators in LPS-stimulated RAW264.7 macrophages through inhibition of NF-κB pathway and MAPKs activation,” Journal of Ethnopharmacology, vol. 154, no. 3, pp. 711–718, 2014.
View at: Publisher Site | Google Scholar
X. Dai, D. Yang, J. Bao et al., “Er Miao San, a traditional Chinese herbal formula, attenuates complete Freund's adjuvant-induced arthritis in rats by regulating Th17/Treg cells,” Pharmaceutical Biology, vol. 58, no. 1, pp. 157–164, 2020.
View at: Publisher Site | Google Scholar
Q. Zhang, W. Peng, S. Wei et al., “Guizhi-Shaoyao-Zhimu decoction possesses anti-arthritic effects on type II collagen-induced arthritis in rats _via_ suppression of inflammatory reactions, inhibition of invasion & migration and induction of apoptosis in synovial fibroblasts,” Biomedicine & Pharmacotherapy, vol. 118, article 109367, 2019.
View at: Publisher Site | Google Scholar
K. Chen, Z. W. Lin, S. M. He et al., “Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway,” Biomedicine & Pharmacotherapy, vol. 115, article 108875, 2019.
View at: Publisher Site | Google Scholar
M. R. Tanner, M. W. Pennington, S. S. Chauhan, T. Laragione, P. S. Gulko, and C. Beeton, “KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis,” Arthritis Research & Therapy, vol. 21, no. 1, p. 6, 2019.
View at: Publisher Site | Google Scholar
I. B. Mc Innes and G. Schett, “Pathogenetic insights from the treatment of rheumatoid arthritis,” The Lancet, vol. 389, no. 10086, pp. 2328–2337, 2017.
View at: Publisher Site | Google Scholar
J. P. Matson and J. G. Cook, “Cell cycle proliferation decisions: the impact of single cell analyses,” The FEBS Journal, vol. 284, no. 3, pp. 362–375, 2017.
View at: Publisher Site | Google Scholar
X. Zhang, H. Feng, J. du et al., “Aspirin promotes apoptosis and inhibits proliferation by blocking G0/G1 into S phase in rheumatoid arthritis fibroblast-like synoviocytes via downregulation of JAK/STAT3 and NF-κB signaling pathway,” International Journal of Molecular Medicine, vol. 42, pp. 3135–3148, 2018.
View at: Publisher Site | Google Scholar
K. Chaabo and B. Kirkham, “Rheumatoid Arthritis - Anti-TNF,” International Immunopharmacology, vol. 27, pp. 180–184, 2015.
View at: Google Scholar
C. E. Page, S. Smale, S. M. Carty et al., “Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis,” Arthritis Research & Therapy, vol. 12, p. R49, 2010.
View at: Publisher Site | Google Scholar
C. Angiolilli, A. M. Grabiec, B. S. Ferguson et al., “Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression,” Annals of the Rheumatic Diseases, vol. 75, no. 2, pp. 430–438, 2016.
View at: Publisher Site | Google Scholar
J. Liu and Y. Sun, “How does Chinese medicine target cytokine imbalance in rheumatoid arthritis,” Chinese Journal of Integrative Medicine, vol. 19, no. 11, pp. 874–880, 2013.
View at: Publisher Site | Google Scholar
K. F. Zhai, H. Duan, C. Y. Cui et al., “Liquiritin fromGlycyrrhiza uralensisattenuating rheumatoid arthritis via reducing inflammation, suppressing angiogenesis, and inhibiting MAPK signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 67, no. 10, pp. 2856–2864, 2019.
View at: Publisher Site | Google Scholar
L. Zhang, J. Luo, H. Wen, T. Zhang, X. Zuo, and X. Li, “MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB,” International Immunopharmacology, vol. 30, pp. 69–73, 2016.
View at: Publisher Site | Google Scholar
L. Xu, X. Feng, Y. Shi et al., “Interleukin-29 induces receptor activator of NF-κB ligand expression in fibroblast-like synoviocytes via MAPK signaling pathways,” International Journal of Rheumatic Diseases, vol. 18, no. 8, pp. 842–849, 2015.
View at: Publisher Site | Google Scholar
L. Liang, M. Huang, Y. Xiao et al., “Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis,” Inflammation Research, vol. 64, no. 3-4, pp. 225–233, 2015.
View at: Publisher Site | Google Scholar
Q. F. Zou, L. Li, Q. R. Han, Y. J. Wang, and X. B. Wang, “Abatacept alleviates rheumatoid arthritis development by inhibiting migration of fibroblast-like synoviocytes via MAPK pathway,” European Review for Medical and Pharmacological Sciences, vol. 23, pp. 3105–3111, 2019.
View at: Google Scholar
H. Ji, H. Wang, F. Zhang, X. Li, L. Xiang, and S. Aiguo, “PPARγ agonist pioglitazone inhibits microglia inflammation by blocking p38 mitogen-activated protein kinase signaling pathways,” Inflammation Research, vol. 59, pp. 921–929, 2010.
View at: Publisher Site | Google Scholar
J. Li, B. Xu, Z. Chen et al., “PI3K/AKT/JNK/p38 signalling pathway-mediated neural apoptosis in the prefrontal cortex of mice is involved in the antidepressant-like effect of pioglitazone,” vol. 45, pp. 525–535, 2018.
View at: Publisher Site | Google Scholar
P. Bork, “The modular architecture of a new family of growth regulators related to connective tissue growth factor,” FEBS Letters, vol. 327, pp. 125–130, 1993.
View at: Publisher Site | Google Scholar
W. Wang, F. Liu, and N. Chen, “Peroxisome proliferator-activated receptor-γ (PPAR-γ) agonists attenuate the profibrotic response induced by TGF-β1 in renal interstitial fibroblasts,” Mediators of Inflammation, vol. 2007, Article ID 62641, 7 pages, 2007.
View at: Publisher Site | Google Scholar
Y. L. Cao, Y. Duan, L. X. Zhu, Y. N. Zhan, S. X. Min, and A. M. Jin, “TGF-β1, in association with the increased expression of connective tissue growth factor, induce the hypertrophy of the ligamentum flavum cthrough the p38 MAPK pathway,” International Journal of Molecular Medicine, vol. 38, no. 2, pp. 391–398, 2016.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2021 Ying Han et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

666

Downloads

1273

Citations